(Q38351819)

2 September 2017

title

Putting some spine into alternative splicing (English)

1 reference

alternative mRNA splicing, via spliceosome

2 September 2017

main subject

1 reference

Bernard Khoo

1

1 reference

2 September 2017

Scott A Akker

series ordinal

2

1 reference

2 September 2017

Shern L Chew

series ordinal

3

1 reference

2 September 2017

publication date

1 August 2003

1 reference

2 September 2017

published in

Trends in Biotechnology

1 reference

2 September 2017

volume

21

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

328-330

1 reference

Identification and characterization of a spinal muscular atrophy-determining gene

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

The SMN complex, an assemblyosome of ribonucleoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

The molecular bases of spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Correction of disease-associated exon skipping by synthetic exon-specific activators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Treatment of spinal muscular atrophy by sodium butyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

A Short-Term Trial of Butyrate to Stimulate Fetal-Globin-Gene Expression in the β-Globin Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Recent developments in the field of antitumour anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Brain-specific expression of an exogenous gene after i.v. administration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Drug and gene targeting to the brain with molecular Trojan horses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Antisense imaging of gene expression in the brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

Listening to silence and understanding nonsense: exonic mutations that affect splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2803%2900168-9

7 January 2021

10.1016/S0167-7799(03)00168-9

Identifiers

DOI

1 reference

2 September 2017

1 reference